Cardlytics, Inc. (CDLX)
$
1.76
+0.06 (3.41%)
Key metrics
Financial statements
Free cash flow per share
-0.2403
Market cap
92.4 Million
Price to sales ratio
0.3390
Debt to equity
3.4440
Current ratio
1.1894
Income quality
-0.0117
Average inventory
0
ROE
-1.7236
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom, recording a notable revenue of $278,298,000.00 showcasing its steady growth. The earnings per share (EPS) is reported at -$3.91 indicating the company's profitability on a per-share basis. Additionally, the net total of other income and expenses is $6,195,000.00 reflecting non-core financial activities. The company recorded an operating income of -$195,499,000.00 which reflects its earnings from core operations. Furthermore, the company incurred an income tax expense of $0.00 indicating its tax obligations. Founded in 2008 and headquartered in Atlanta, Georgia, Cardlytics provides innovative solutions through its Cardlytics platform, a proprietary native bank advertising channel, allowing marketers to connect with customers via various digital channels such as online, mobile applications, email, and real-time notifications. The Bridg platform complements this by offering a customer data platform that leverages point-of-sale data for analytics, targeted loyalty marketing, and measuring marketing impact. Currently, the stock is affordable at $1.76 making it suitable for budget-conscious investors. The stock has an average trading volume of 1,055,682.00 indicating moderate liquidity within the market. With a market capitalization of $92,404,224.00 the company is classified as a small-cap player, which often presents unique opportunities and risks. As a key player in the Advertising Agencies industry, Cardlytics contributes significantly to the overall market landscape while belonging to the Communication Services sector, thus driving innovation and growth. Through its comprehensive advertising solutions and data-driven insights, Cardlytics is positioned to play an essential role in the evolving landscape of digital marketing in the financial services domain.
Is Cardlytics, Inc. (CDLX) a good investment?
Investing in Cardlytics, Inc. (CDLX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bearish outlook. Always conduct your own research before investing.
What is Cardlytics, Inc. (CDLX)'s stock forecast?
Analysts predict Cardlytics, Inc. stock to fluctuate between $1.22 (low) and $9.78 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Cardlytics, Inc.'s market capitalization?
As of 2025-06-04, Cardlytics, Inc.'s market cap is $92,404,224, based on 52,502,400 outstanding shares.
How does Cardlytics, Inc. compare to competitors like Nvidia Corp?
Compared to Nvidia Corp, Cardlytics, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Cardlytics, Inc. (CDLX) stock?
To buy Cardlytics, Inc. (CDLX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CDLX. Place an order (Market, Limit, etc.).
What is the best time to invest in Cardlytics, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Cardlytics, Inc. perform in the last earnings report?
Revenue: $278,298,000 | EPS: -$3.91 | Growth: 5.96%.
Where can I find Cardlytics, Inc.'s investor relations reports?
Visit https://www.cardlytics.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Cardlytics, Inc.?
You can explore historical data from here
What is the all-time high and low for Cardlytics, Inc. stock?
All-time high: $161.47 (2021-02-16) | All-time low: $1.22 (2025-04-08).
What are the key trends affecting Cardlytics, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
We maintain our Strong Buy on Cardlytics and issue a PT of $6, despite the near-term revenue reset and slower monetization from new partners. The Amex channel is a game-changer, offering high-margin, immediate profitability with minimal incremental OpEx, supporting a clear path to EBITDA recovery. EBP and platform diversification are driving structural margin expansion, de-risking revenue and opening new high-engagement verticals for scalable growth.
businesswire.com
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the general availability of Cardlytics Rewards Platform (CRP), a new solution that provides publishers the opportunity to enhance their customer loyalty programs with card-linked offers. With CRP, a merchant with digital channels and a loyalty program can now become a publisher on the Cardlytics network and offer more value to their customers. Building on its longstanding leadership in financial media, Cardlytics is expand.
seekingalpha.com
Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal and Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Luke Horton - Northland Capital Markets Robert Coolbrith - Evercore Cal Bartyzal - Craig-Hallum Operator Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, May 7, 2025.
zacks.com
Cardlytics (CDLX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.09 per share a year ago.
businesswire.com
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For.
globenewswire.com
NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
accessnewswire.com
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=137631&wire=1 or contact Joseph E. Levi, Esq.
prnewswire.com
NEW YORK , March 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024.
prnewswire.com
NEW YORK , March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
prnewswire.com
NEW YORK , March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024.
See all news
